Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AVBP | MLTX | BBOT | ||
| Company | Arrivent Biopharma Inc | Moonlake Immunotherapeutics | Bridgebio Oncology Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.49 | 14.26 | 11.94 | ||
| High | 24.41 | 15.36 | 12.48 | ||
| Low | 22.75 | 14.26 | 11.75 | ||
| Latest | 23.11 | 15.34 | 11.85 | ||
| Change | -0.53 | +1.02 | -0.15 | ||
| % Change | -2.24% | +7.12% | -1.25% | ||
| Volume | 477,300 | 2,421,000 | 140,300 | ||
| 20-Day Average Volume | 379,650 | 2,046,405 | 164,385 | ||
| Previous Close | 23.64 | 14.32 | 12.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 22.79 | 13.93 | 12.38 | ||
| 20-Day Raw Stochastic | 54.38% | 93.12% | 27.92% | ||
| 20-Day Relative Strength | 56.02 | 50.12 | 47.79 | ||
| Weighted Alpha | -2.52 | +107.42 | +10.53 | ||
| Today's Opinion | 88% Buy | 40% Sell | 64% Buy | ||
| Previous Opinion | 88% Buy | 40% Sell | 64% Buy | ||
| Last Month's Opinion | 24% Sell | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.23% since 12/09/25 | +5.43% since 12/09/25 | -5.43% since 12/09/25 | ||
| Low | 22.75 on 12/16/25 | 13.87 on 12/11/25 | 11.75 on 12/16/25 | ||
| High | 25.80 on 12/10/25 | 15.36 on 12/16/25 | 13.58 on 12/11/25 | ||
| 1-Month | |||||
| %Chg | +11.70% since 11/14/25 | +20.13% since 11/14/25 | -9.68% since 11/14/25 | ||
| Low | 19.88 on 11/21/25 | 12.43 on 11/21/25 | 10.68 on 12/03/25 | ||
| High | 25.82 on 12/08/25 | 15.56 on 12/08/25 | 14.87 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +26.98% since 09/16/25 | -71.20% since 09/16/25 | +18.62% since 09/16/25 | ||
| Low | 17.00 on 11/03/25 | 5.95 on 09/29/25 | 10.15 on 09/17/25 | ||
| High | 25.82 on 12/08/25 | 62.75 on 09/26/25 | 14.87 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | -9.09% since 06/16/25 | -64.24% since 06/16/25 | +9.52% since 06/16/25 | ||
| Low | 16.10 on 08/12/25 | 5.95 on 09/29/25 | 8.50 on 08/05/25 | ||
| High | 25.82 on 12/08/25 | 62.75 on 09/26/25 | 14.87 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 954,004 | 985,304 | 947,870 | ||
| Shares Outstanding, K | 41,281 | 64,231 | 79,989 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -80,490,000 | -118,940,000 | -74,275,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -34,980,000 | -69,730,000 | -44,757,000 | ||
| 60-Month Beta | 0.95 | 1.21 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.83 on 11/10/25 | -1.10 on 11/05/25 | -1.03 on 11/12/25 | ||
| Latest Earnings Date | 03/02/26 | 02/25/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||